Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading ->
Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading ->
Criminalisation of HIV/AIDS transmission, a widespread phenomenon in Africa, is undermining efforts towards fighting the disease. This emerged during the Science Forum South Africa (SFSA), attended by some 3,000 researchers, scientists, policymakers and students from all over the world. The forum, which ran from 12-14 December in Pretoria, is Africa’s premier science, technology and innovation event. Continue reading ->
NAIROBI, Kenya – Kenyan President Uhuru Kenyatta today announced the launch of a universal health coverage (UHC) plan, positioning Kenya as a leader in achieving quality and affordable healthcare in the African continent. Meanwhile, the World Health Organization top management used the opportunity to announce some changes in the way the organisation works. Continue reading ->